FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
NASDAQ:IMNP
Delisted

Immune Pharmaceuticals Inc. Stock Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.0032
+0 (+0%)
At Close: Mar 05, 2019
Forecast Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0023 $0.0100 Tuesday, 5th Mar 2019 IMNP stock ended at $0.0032. During the day the stock fluctuated 0% from a day low at $0.0032 to a day high of $0.0032.
90 days $0.0023 $0.0248
52 weeks $0.0023 $0.420

Historical Immune Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Mar 05, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Mar 04, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Mar 01, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 28, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 27, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 26, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 25, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 22, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 21, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 20, 2019 $0.0032 $0.0032 $0.0032 $0.0032 0
Feb 19, 2019 $0.0045 $0.0051 $0.0023 $0.0032 29 099 001
Feb 15, 2019 $0.0100 $0.0100 $0.0100 $0.0100 13 859 196
Feb 14, 2019 $0.0100 $0.0100 $0.0100 $0.0100 2 408 163
Feb 13, 2019 $0.0100 $0.0100 $0.0100 $0.0100 656 484
Feb 12, 2019 $0.0100 $0.0100 $0.0100 $0.0100 1 087 962
Feb 11, 2019 $0.0080 $0.0080 $0.0055 $0.0063 3 995 423
Feb 08, 2019 $0.0062 $0.0070 $0.0061 $0.0065 2 987 000
Feb 07, 2019 $0.0080 $0.0080 $0.0068 $0.0080 3 110 474
Feb 06, 2019 $0.0090 $0.0090 $0.0078 $0.0083 4 576 891
Feb 05, 2019 $0.0076 $0.0090 $0.0075 $0.0078 1 788 401
Feb 04, 2019 $0.0069 $0.0095 $0.0069 $0.0078 3 520 770
Feb 01, 2019 $0.0074 $0.0077 $0.0066 $0.0075 1 764 098
Jan 31, 2019 $0.0123 $0.0123 $0.0072 $0.0074 6 340 071
Jan 30, 2019 $0.0082 $0.0088 $0.0072 $0.0081 9 068 645
Jan 29, 2019 $0.0064 $0.0089 $0.0061 $0.0080 8 317 574
Click to get the best stock tips daily for free!

About Immune Pharmaceuticals Inc.

Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company’s lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. It is also developing NanoCyclo, a topical nanocapsule formulati... IMNP Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 1.95% $11.28
MLI Apr 19 11.07% $52.28
LPLA Apr 19 4.31% $262.59
DOOR Apr 18 0.90% $131.39
PFLT Apr 18 1.78% $11.25
LNG Apr 17 3.12% $156.81
FCN Apr 16 2.83% $207.62
ELV Apr 16 5.33% $506.97
AKR Apr 05 6.47% $16.53
ITCI Apr 05 5.64% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT